A long-awaited study commissioned by the FDA has muddied the path forward on how to reduce racial bias in pulse oximeter ...

A federal jury in California ruled Friday that Apple owes Masimo $634 million for infringing a blood-oxygen monitoring patent behind those little glowing sensors on your wrist. Trump canceling GDP ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

A federal jury in the U.S. District Court for the Central District of California has ruled that Apple must pay $634 million to Masimo for allegedly infringing on a patent covering ‌blood-oxygen ...

A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology. Reuters reports the jury found ...

It hasn't even been a week since Apple reintroduced the blood oxygen feature to its US-based Apple Watch users. But Masimo has filed a lawsuit against US Customs and Border Protection (CBP), accusing ...

Masimo, the medical technology company whose lawsuit led to the temporary sales pause of the Apple Watch Series 9 and Ultra 2, has sued the US Customs and Border Protection days after Apple released ...

Masimo is taking the U.S. government to court over its decision to allow blood oxygen tracking to return to the Apple Watch, saying its decision was unlawful and that Apple’s workaround still ...

Medical technology company Masimo on Wednesday filed a lawsuit against U.S. Customs and Border Protection in which it challenged the agency's decision to allow Apple to restore blood oxygen monitoring ...

Masimo (NASDAQ:MASI) filed a lawsuit against U.S. Customs and Border Protection over a decision that allowed Apple (NASDAQ:AAPL) to import Apple Watches with blood-oxygen feature technology during a ...